These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 12772203
1. Apolipoprotein D expression in cutaneous malignant melanoma. Miranda E, Vizoso F, Martín A, Quintela I, Corte MD, Seguí ME, Ordiz I, Merino AM. J Surg Oncol; 2003 Jun; 83(2):99-105. PubMed ID: 12772203 [Abstract] [Full Text] [Related]
2. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas? Kaleem Z, Lind AC, Humphrey PA, Sueper RH, Swanson PE, Ritter JH, Wick MR. Mod Pathol; 2000 Mar; 13(3):217-22. PubMed ID: 10757331 [Abstract] [Full Text] [Related]
3. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions. Simonetti O, Lucarini G, Brancorsini D, Nita P, Bernardini ML, Biagini G, Offidani A. Cancer; 2002 Nov 01; 95(9):1963-70. PubMed ID: 12404291 [Abstract] [Full Text] [Related]
4. [Expression of galanin in melanocytic tumors]. Gilaberte Y, Vera J, Coscojuela C, Roca MJ, Parrado C, González S. Actas Dermosifiliogr; 2007 Nov 01; 98(1):24-34. PubMed ID: 17374330 [Abstract] [Full Text] [Related]
8. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions. Nasr MR, El-Zammar O. Am J Dermatopathol; 2008 Apr 01; 30(2):117-22. PubMed ID: 18360113 [Abstract] [Full Text] [Related]
9. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters. Busam KJ, Iversen K, Berwick M, Spagnoli GC, Old LJ, Jungbluth AA. Mod Pathol; 2000 Apr 01; 13(4):459-65. PubMed ID: 10786815 [Abstract] [Full Text] [Related]
11. The role of vascular endothelial growth factors and their receptors in malignant melanomas. Brychtova S, Bezdekova M, Brychta T, Tichy M. Neoplasma; 2008 Apr 01; 55(4):273-9. PubMed ID: 18505336 [Abstract] [Full Text] [Related]
12. Expression and clinical significance of apolipoprotein D in male breast cancer and gynaecomastia. Serra Díaz C, Vizoso F, Lamelas ML, Rodríguez JC, González LO, Baltasar A, Medrano J. Br J Surg; 1999 Sep 01; 86(9):1190-7. PubMed ID: 10504376 [Abstract] [Full Text] [Related]
14. MSG-1 expression in benign and malignant melanocytic lesions of cutaneous and mucosal epithelium. Sedghizadeh PP, Williams JD, Allen CM, Prasad ML. Med Sci Monit; 2005 Jul 01; 11(7):BR189-94. PubMed ID: 15990678 [Abstract] [Full Text] [Related]
18. Cyclin D1 expression in melanocytic lesions of the skin. Ramirez JA, Guitart J, Rao MS, Diaz LK. Ann Diagn Pathol; 2005 Aug 01; 9(4):185-8. PubMed ID: 16084449 [Abstract] [Full Text] [Related]
19. Immunohistochemical analysis of the S100A1, S100B, CD44 and Bcl-2 antigens and the rate of cell proliferation assessed by Ki-67 antibody in benign and malignant melanocytic tumours. Sviatoha V, Tani E, Kleina R, Sperga M, Skoog L. Melanoma Res; 2010 Apr 01; 20(2):118-25. PubMed ID: 20042890 [Abstract] [Full Text] [Related]
20. Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome. Flørenes VA, Maelandsmo GM, Faye R, Nesland JM, Holm R. J Pathol; 2001 Dec 01; 195(5):530-6. PubMed ID: 11745687 [Abstract] [Full Text] [Related] Page: [Next] [New Search]